30Ventures

30Ventures is a venture capital firm based in Madison, Wisconsin, established in 2017. The firm specializes in early-stage investments, particularly in Series A and B financing rounds, targeting high-potential companies within the healthcare and biotechnology sectors. Its focus areas include medical diagnostics, biotechnology tools, medical devices, and technologies related to industrial water and chemistry. 30Ventures is dedicated to fostering innovation in the Midwest, supporting startups that are poised to make significant impacts on human healthcare. The principals of the firm possess extensive experience in commercializing innovation, positioning them as key players in the regional entrepreneurial ecosystem.

George Arida

Founder and Managing Director

5 past transactions

AIQ Solutions

Series A in 2019
AIQ Solutions is a medical device company based in Madison, Wisconsin, that develops quantitative imaging platforms for assessing cancer lesions. Founded in 2015 by researchers from the University of Wisconsin Carbone Cancer Center, the company builds software and hardware that automatically localizes every lesion on molecular imaging studies and calculates standardized uptake value metrics to measure disease burden and treatment response. Its flagship products include the Quantitative Total Bone Imaging (QTBI) device, which provides detailed insight into metastatic bone disease from prostate or breast cancer, and the Quantitative Total Marrow Imaging (QTMI) system, which evaluates marrow heterogeneity and response to therapy. The QTxI platform received FDA 510(k) clearance in 2018 and is licensed to the Wisconsin Alumni Research Foundation. AIQ Solutions serves oncologists, radiologists, nuclear medicine physicians, and pharmaceutical companies, aiming to improve patient outcomes and reduce healthcare costs.

Pops Diabetes Care

Series A in 2019
Pops Diabetes Care offers a virtual healthcare platform for people with diabetes. It uses consumer-centric sensors and AI-driven virtual coaches to help users manage their condition effectively, leading to potential savings of over $2,000 annually per user.

Somna Therapeutics

Venture Round in 2018
Somna Therapeutics LLC, founded in March 2012 in partnership with the Medical College of Wisconsin, is a medical device company based in Germantown, Wisconsin. The company specializes in developing solutions for laryngopharyngeal reflux (LPR) and extraesophageal acid reflux diseases (EERD). Its primary product, the Reza Band, is a non-pharmacologic, investigational device designed to prevent reflux into the larynx, pharynx, and lungs. This non-invasive device aims to improve the quality of life for individuals suffering from these conditions. Somna Therapeutics is currently focused on optimizing product design and completing clinical trials to obtain FDA clearance, with plans to market the Reza Band to hospitals, physician clinics, and home health care providers upon successful approval and launch.

Made In Cookware

Seed Round in 2018
Made In Cookware is a premium American cookware brand that designs, manufactures, and distributes a variety of kitchen products, including frying pans, saucepans, sauté pans, stock pots, and accessories. Founded in 2016 and based in Boston, Massachusetts, the company focuses on providing high-quality cookware at affordable prices through a direct-to-consumer e-commerce platform. Made In aims to become the preferred kitchen brand for modern cooks, particularly targeting Millennials across diverse culinary categories.

TAI Diagnostics

Series A in 2018
TAI Diagnostics, Inc. is a biotechnology company founded in 2013 and based in Wauwatosa, Wisconsin. It specializes in developing a non-invasive and highly sensitive diagnostic test aimed at monitoring the health of transplanted organs in patients who have undergone solid organ transplants. Utilizing advanced cell-free DNA (cf-DNA) technology, TAI Diagnostics provides a direct measurement of organ injury by quantifying donor-specific cf-DNA released into the bloodstream from damaged cells of transplanted organs. This innovative approach enables physicians to detect organ rejection at an early stage and conduct regular surveillance biopsies, ultimately enhancing patient outcomes in transplant care. The company is strategically located in the Milwaukee County Research Park, near key medical research institutions.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.